Home » Topics » Regulatory » EMA

EMA
RSS

EMA's CHMP issues positive opinion regarding afatinib

July 31, 2013

Simponi gets positive opinion in Europe for ulcerative colitis

July 30, 2013

Stelara receives positive CHMP recommendation

July 30, 2013

Eisai receives positive CHMP opinion for Zonegran in pediatric patients

July 30, 2013

Gilead receives positive opinion from EMA for cobicistat

July 29, 2013

Novartis' dual bronchodilator QVA-149 recommended for approval in COPD by CHMP

July 29, 2013

EMA issues negative opinion on delamanid for tuberculosis

July 29, 2013

EMA committee recommends approval of Revolade expanded indication

July 29, 2013

EMA's CHMP recommends approval of VEGF Trap-Eye/Eylea for new indication

July 29, 2013

EMA committee recommends Defitelio approval under exceptional circumstances

July 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...